Knight Therapeutics | GUD - Operating Profit



Knight Therapeutics reported CAD3.2M in Operating Profit for its fiscal quarter ending in September of 2024.


Operating Profit Change Date
Acasti Pharma USD -3090000 614K Jun/2025
Alaunos Therapeutics USD -755000 395K Dec/2024
Aurora Cannabis CAD -20220000 56.44M Jun/2025
Avita Medical AUD -9957000 5.64M Dec/2024
Canopy Growth CAD -22080000 1.74M Jun/2025
Cronos Group USD -4384000 312K Jun/2025
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Moderna USD -907000000 143M Jun/2025
Organigram Holdings CAD -2100000 9.2M Jun/2025
Organon & Co USD 326M 225M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Tectonic Therapeutic USD -22330000 8.34M Jun/2025
Tilray USD -42218000 5.65M Nov/2024
Viatris USD 185.4M 3.21B Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025